All News

New drugs, indications, generics, and over-the-counter products for sale in pharmacies.

A growing number of retail pharmacies are looking to automation technology as they expand their businesses beyond lick, stick, and pour.

A delay in AMP implementation, prompt pay for Medicare Part D claims, and e-pedigree are among the major issues addressed at the NCPA legislative show.

Manufacturers are unleashing new oral care over-the-counter products that are innovative.

John Gans tallks candidly about his role at APhA, his departure from APhA and other timely matters affecting the future of pharmacy.

NHLBI debuts new guidelines for treatment of von Willebrand Disease

At the AHIP annual meeting, CVS Caremark announced a new approach to managing patients' medication needs.

Impressive study results lead to new Velcade indication.

Now pediatric patients, too, can take Aptpivus to treat HIV.

In settling a class action suit, the Centers for Medicare & Medicaid Services has agreed to make changes to the low income subsidy program for Medicare Part D.

Sanofi-Pasteur's new Pentacel vaccine is cleared to protect against five childhood diseases.

One change involves prohibiting drug companies from distributing noneducational items to healthcare providers.

This capability enables patients to store and access their health records securely.

Bill would also reward physicians for acquiring and using electronic prescribing technology.

At least 17 babies in the neonatal intensive care unit at a hospital in Corpus Christi, Texas, were given overdoses of the blood thinner heparin.

This is the first organ-specific magnetic resonance imaging contrast agent approved in this country in more than a decade.

More than 300 generics will be available.

Certain hospitals in Horizon Blue Cross Blue Shield of New Jersey's network can pull electronic medication histories of patients in real time.

Pharmacists must give out a Medication Guide when dispensing these antimicrobial drugs.

One new program helps independents buy or sell a pharmacy.

The acquisition price is estimated at up to $5.6 billion.

California Pharmacists Association is upset with ruling.

Charity arm of CVS also donates cash to Red Cross for state efforts.

Pennsylvania Patient Safety Authority reviews more than 800 hospital reports.

Company claims mailing back used syringes is cost effective.

Both stents are designed to treat coronary artery disease.

Supplements pulled due to undeclared ingredient.

Suit was brought by the Alabama Attorney General against 73 pharmaceutical manufacturers.